UK Life Sciences Company Directory

Synthetic and medicinal chemistry contract research for drug discovery

AF ChemPharm is a contract research organisation providing synthetic organic and medicinal chemistry services to pharmaceutical, biotechnology, academic and chemical industry clients. Its team of PhD chemists carries out custom synthesis of target compounds from milligram to kilogram scale, contract research and…

Therapeutic antibodies targeting the angiotensin AT1R pathway in cancer

aTen Therapeutics is a Scottish pre-clinical biotechnology company developing therapeutic monoclonal antibodies against the angiotensin-II type I receptor (AT1R), which is overexpressed across a range of cancers. Its lead candidate, Tensinumab (ATN-E11), is a human monoclonal antibody generated via phage display that…

Purpose-built technology and life science campus near Cambridge

TTP Campus is a bespoke research and technology campus located in Melbourn, Cambridgeshire, developed and operated by TTP Group. The campus houses TTP plc alongside a growing cluster of spinout companies. Facilities include CL2 wet laboratories, chemistry labs, low-vibration suites for laser and optics work, advanced…

AI-enabled personalised dosing for drug-digital combination therapies

Closed Loop Medicine develops combination products integrating pharmaceutical therapies with AI-powered digital companions to personalise drug dosing for chronic conditions. Its platform applies pharmacometric modelling and patient response data to optimise treatment regimens. The pipeline includes co-packaged drug…

Small molecule neuromodulators for neuropsychiatric disorders

Draig Therapeutics is a clinical-stage biotech developing small molecule drugs that modulate the glutamate and GABA neurotransmitter pathways to treat neuropsychiatric disorders. Its lead candidate DT-101 is an AMPA receptor positive allosteric modulator in Phase 2 development for major depressive disorder. The…

Computational cell models for novel drug target discovery

Oppilotech is a UK biotechnology company that uses systems biology and machine learning to build high-resolution computational models of cells and bacteria. Its proprietary platform simulates biochemical pathways to identify viable drug targets and generate first-in-class discovery programmes. The company's primary…

Bio-based polyurethane alternatives from agricultural waste and seaweed

AlGreen is an industrial biotechnology company developing bio-based alternatives to petroleum-derived polyurethanes, which account for approximately 8% of global plastics. Using biotechnology, chemistry, and materials science, the company synthesises fully biodegradable, high-performance polyurethane substitutes from…

Microalgal fermentation for sustainable EPA omega-3 and protein

AlgiSys develops fermentation-based biotechnology for producing eicosapentaenoic acid (EPA) omega-3 oils and protein-rich biomass from microalgae. Its proprietary heterotrophic algal strains grow in industrial fermentation systems without light, offering an alternative to extracting omega-3 ingredients from fish or…

Diagnostic reagents, allergy testing products and contract diagnostics manufacturing

Bio-Diagnostics is a manufacturer of diagnostic products and provider of contract services for the in vitro diagnostics industry. Its own range covers reagents and tests for infectious disease, autoimmunity and immunohistochemistry, alongside an extensive portfolio of allergens and accessories for patch and skin prick…

Cell and gene therapy CDMO with integrated consultancy services

eXmoor Pharma is a Bristol-based contract development and manufacturing organisation specialising in cell and gene therapies. Operating from a 65,000 sq ft MHRA-licensed GMP facility, the company provides services spanning process development, viral vector and cell therapy manufacture, fill and finish, and QP release.…

Non-viral intracellular drug delivery for solid tumours

Vitarka Therapeutics is a preclinical biotech company developing a non-viral drug delivery platform for targeted intracellular delivery of therapeutics to solid tumours. The technology uses pore-forming proteins to transport RNAi therapies and other payloads directly into cancer cells while limiting off-target…

Genetically engineered insects for sustainable pest and disease vector control

Flyttr is an Oxfordshire-based biotechnology company developing biological solutions for sustainable pest management. Its core technology uses genetically engineered insects carrying a self-limiting gene to suppress populations of disease-transmitting and crop-damaging pests without chemicals or harm to non-target…

Non-invasive mitochondrial DNA damage testing for skin health research

Skin Life Analytics is a biotechnology company providing PCR-based testing services that quantify mitochondrial DNA damage in skin using non-invasive swab sampling. The technology detects molecular markers of skin ageing, UV damage, and environmental stress before visible signs appear. Services include direct testing…

Protein superglue vaccine platform targeting infectious disease and cancer

SpyBiotech is a clinical-stage biotechnology company developing vaccines using its proprietary protein superglue technology, which enables efficient and stable attachment of antigens to virus-like particle and viral vector delivery platforms. The approach improves immunogenicity and reduces manufacturing complexity…

Medtech and life science incubator on the Boots campus

MediCity Nottingham is a life science and medtech incubator located within the Nottingham Enterprise Zone on the Boots UK campus in Beeston. Operated by Pioneer Group, it provides flexible laboratory and office space alongside business support for start-up and established companies in consumer healthcare, medical…

Research community connecting organoid and organ-on-a-chip scientists

WORC.Community is a research network connecting scientists working with organoids, organ-on-a-chip technologies and other new approach methodologies. Its online platform brings together scientific publications, research protocols, community discussions, networking opportunities and relevant events. WORC.Community also…

Life science incubator and laboratory space in Whitechapel

Queen Mary BioEnterprises is a wholly owned subsidiary of Queen Mary Innovation, the technology transfer arm of Queen Mary University of London. It operates the QMB Innovation Centre in Whitechapel, east London, providing 39,000 square feet of CL2 wet laboratory and office space for early and late-stage life science…

Medical imaging CRO and AI platform for clinical trials

Image Analysis Group is a specialist imaging contract research organisation serving biotech and pharmaceutical companies across all clinical trial phases. The company designs and executes imaging-based efficacy and safety endpoints, provides centralised independent radiological review, and delivers quantitative image…

Galectin-3 targeted small molecule therapeutics for cancer and fibrosis

Galytx is a University of Liverpool spin-out developing small molecule therapeutic drugs that target galectin-3, a protein closely associated with cancer, fibrosis and inflammatory disease. The company's portfolio includes a repurposed clinical-stage asset with an established safety record, alongside pre-clinical…

Cell-based regenerative therapies for heart failure

Cardiogeni is a clinical-stage biotechnology group developing regenerative cell medicines for cardiovascular disease. Its lead programme, CLXR-001, uses engineered immunomodulatory progenitor cells intended to support repair of damaged heart tissue in patients with heart failure. The group is progressing plans for…